Safety, effectiveness, and adherence of a short and all-oral treatment regimen for the treatment of rifampicin-resistant tuberculosis in Niger: a study protocol of a pragmatic randomised clinical trial with stratified block randomisation.

Souleymane, Mahamadou Bassirou; Decroo, Tom; Soumana, Alphazazi; Maman Lawan, Ibrahim; Gagara-Issoufou, Assiatou; Halidou-Moussa, Souleymane; Ortuño-Gutiérrez, Nimer; Adehossi, Eric; Mamadou, Saïdou; Van Deun, Armand; Piubello, Alberto

Souleymane, Mahamadou Bassirou; Decroo, Tom; Soumana, Alphazazi; Maman Lawan, Ibrahim; Gagara-Issoufou, Assiatou; Halidou-Moussa, Souleymane; Ortuño-Gutiérrez, Nimer; Adehossi, Eric; Mamadou, Saïdou; Van Deun, Armand; Piubello, Alberto.

Afiliação

Souleymane MB; Damien Foundation, Niamey, Niger. bachirsoul@gmail.com.
Decroo T; Institute of Tropical Medicine, Antwerp, Belgium.
Soumana A; Research Foundation Flanders, Brussels, Belgium.
Maman Lawan I; Programme National de Lutte contre la Tuberculose, Programme, Niamey, Niger.
Gagara-Issoufou A; Damien Foundation, Niamey, Niger.
Halidou-Moussa S; Université Abdou Moumouni de Niamey, Faculté des Science de la Santé, Niamey, Niger.
Ortuño-Gutiérrez N; Hopital National Amirou Boubacar Diallo, Pneumo-phtysiologie, Niamey, Niger.
Adehossi E; Damien Foundation, Brussels, Belgium.
Mamadou S; Université Abdou Moumouni de Niamey, Faculté des Science de la Santé, Niamey, Niger.
Van Deun A; Université Abdou Moumouni de Niamey, Faculté des Science de la Santé, Niamey, Niger.
Piubello A; Independent Consultant, Leuven, Belgium.

Trials ; 23(1): 1011, 2022 Dec 13.

Article em En | MEDLINE | ID: mdl-36514153

Assuntos

Tuberculose Resistente a Múltiplos Medicamentos; Tuberculose Pulmonar; Humanos; Rifampina/efeitos adversos; Linezolida/efeitos adversos; Tuberculose Pulmonar/diagnóstico; Níger; Tuberculose Resistente a Múltiplos Medicamentos/diagnóstico; Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico; Antituberculosos/efeitos adversos; Ensaios Clínicos Controlados Aleatórios como Assunto

Palavras-chave

All oral treatment; New anti-tuberculosis drugs; Niger; Rifampicin resistance tuberculosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Pulmonar / Tuberculose Resistente a Múltiplos Medicamentos Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Qualitative_research Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google